From July 24th to 25th, the "2024 Pharmaceutical Third-Party Modern Logistics Service Forum" organized by the Pharmaceutical Chain Circle Platform, supported by the Shaanxi Pharmaceutical Chamber of Commerce, and co-organized by the Shaanxi Pharmaceutical Quality Association and Hangzhou Nenggong Technology Co., Ltd. was held in Xi'an, Shaanxi. With the theme of "The Future is Promising", the forum brought together nearly 400 industry experts, business leaders and representatives from all over the country to jointly take the pulse of the new trend of the pharmaceutical industry, deeply discuss the latest policy orientation, industry development trend and future development strategy of pharmaceutical tripartite logistics, and at the same time, actively explore new opportunities and broad prospects for complementary cooperation between enterprises.

In the field of pharmaceutical circulation, the third-party modern logistics of drugs, as a force to be reckoned with, is increasingly becoming a key link to improve the efficiency of the industry and ensure drug safety. Relying on highly specialized and modern logistics equipment and information technology, this model effectively reduces operating costs, improves service quality, and promotes the comprehensive progress of pharmaceutical logistics in the direction of scale, intensification, standardization, informatization and intelligence through refined management of all aspects of drugs, such as receiving, acceptance, storage, sorting, distribution, etc.

As a leader in the field of pharmaceutical intelligent logistics, ROBO was invited to attend this event, and stood out among many competitors with its deep brand influence, leading product technology, excellent service capabilities and rich industry application cases, and won the honor of "Top Ten Enterprises with Pharmaceutical Intelligent Logistics Technology Service Capabilities".

In the face of the particularity of the pharmaceutical market, ROBO has a deep understanding of the multiple challenges of pharmaceutical distribution enterprises, including the immediacy and uncertainty of meeting terminal demand, the urgency of responding to public health emergencies, and the cyclical fluctuations of production and transportation in the pharmaceutical industry. Based on this, with its forward-looking automated logistics solutions, ROBO has helped many pharmaceutical companies to realize the intelligent upgrade of their logistics systems. Taking Luyan Pharmaceutical's Xiamen Modern Pharmaceutical Intelligent Warehousing and Distribution Center project as an example, RoboTech has successfully helped Luyan Pharmaceutical realize the full automation of warehousing operations, with picking efficiency increased by up to 6 times and overall operational efficiency significantly increased by 50% through customized design solutions, setting a model for pharmaceutical companies to reduce costs, increase efficiency and enhance competitiveness.

Up to now, ROBO has successfully served more than 20 industry leaders, including Luyan Pharmaceutical, Guangzhou Pharmaceutical, Kangrentang, Qidu Pharmaceutical, etc., and has provided nearly 200 sets of intelligent warehousing equipment, which has won wide praise for its professional strength and service quality. As a pioneer in the field of automated warehousing and logistics, ROBO has always focused on the technological innovation and research and development of stackers, shuttles and ancillary equipment, and automated warehouse management system software since its establishment, and is not only the first equipment manufacturer in China to realize the large-scale and mass production of stacker cranes, but also has global sales, operation and service capabilities in more than 20 countries and regions around the world, has accumulated rich industry experience, and formed a profound technical background.

With this award, ROBO will not forget its original intention, deepen the exploration of pharmaceutical smart logistics, take customer needs as the engine, accurately meet industry needs, continue to innovate, consolidate its competitive advantages, and lead the pharmaceutical industry to move towards intelligent and high-quality development.